← Back to catalogue

TegadermTM IV Starter Kit 1633K

EUDAMED

Class IIa (EU MDR)

Ref 1633KRef 061PC09124ARef 061PC09123A

by ITL Asia Pacific Sdn. Bhd.

Identity

Trade Name
TegadermTM IV Starter Kit 1633K EUDAMED
IV Starter Kit EUDAMED
Device Name
Intravenous Starter Kit EUDAMED
IV Start Kit EUDAMED
Model / Reference
1633K EUDAMED
061PC09124A EUDAMED
061PC09123A EUDAMED

Identifiers

Primary DI / UDI-DI
D-1633KHF EUDAMED
09555240406743 EUDAMED
09555240406736 EUDAMED
Basic UDI-DI
B-1633KHF EUDAMED
955524040IVSPR EUDAMED
EMDN Code
V0599 CLINICAL PROCEDURES KITS NOT INCLUDED IN OTHER CLASSES - OTHER EUDAMED

Classification

Device Class
Class IIa EUDAMED
Class I EUDAMED
Medical Purpose
The procedure pack provides the necessary items, required to prepare the skin for an IV cannula insertion and fixation. EUDAMED

Clinical & Handling

Sterile

Yes

EUDAMED

Implantable

No

EUDAMED

Reusable

No

EUDAMED

Contains Latex

No

EUDAMED

Reprocessed

No

EUDAMED

Human-derived

No

EUDAMED

Human Tissues

No

EUDAMED

Animal Tissues

No

EUDAMED

Administering Medicine

No

EUDAMED

Measuring Function

No

EUDAMED

Incorporates Medicinal Product

No

EUDAMED

Category: Ophthalmic surgical procedure kit, non-medicated, single-use

TegadermTM IV Starter Kit 1633K by Itl Asia Pacific Sdn. Bhd. — Class IIa — MDR, MDD — listed in EUDAMED — regulatory data on deviCERTS

Similar devices

Also classified as Ophthalmic surgical procedure kit, non-medicated, single-use.

Authorization Coverage (European Union — 27 member states)

Regulatory Authorizations

European Union Active

CE/MDR

European Union Active

CE/MDD

Is this your device? Claim it to add documentation and request validation.

Manufacturer

EUDAMED SRN
MY-MF-000001570
Authorised Representative
Emergo Europe B.V. NL-AR-000000116

Sources (3)

  • EUDAMED 1f415c0c-c6f0-47d1-8dc7-f115bb32ecc2 61 fields · synced Jul 31, 2026
  • EUDAMED 16e2c527-69f4-4278-9cbe-b4a7c8bd6003 61 fields · synced Jul 12, 2026
  • EUDAMED 0d57dfda-bf11-43c6-89e6-a79ba79d7cd8 61 fields · synced Jul 14, 2026